Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Temporary Suspension

3 Jul 2023 07:00

RNS Number : 6557E
Science in Sport PLC
03 July 2023
 

3 July 2023

Science in Sport plc

("Science in Sport", "the Company" or the "Group")

 

Temporary Suspension

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts, and the active lifestyle community, announces that it has not been able to publish its audited financial statements for the year ended 31 December 2022 by the six month deadline as final sign off from the auditors is still outstanding.

Consequently, the Company's ordinary shares will be suspended from trading on AIM with effect from 8.00 a.m. on 3 July 2023. The suspension will remain in place until the Company's audited financial statements for the year ended 31 December 2022 have been published, which is expected to be imminently.

 

For further information please contact:

For further information:

Science in Sport plc

T: 020 7400 3700

Stephen Moon, CEO

Daniel Lampard, CFO

 

Liberum (Nominated Adviser and Broker)

T: 020 3100 2000

Richard Lindley

William Hall

Lucas Bamber

 

 

Notes to Editors

About Science in Sport plc

Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.

The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and Tmall, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market, sports nutrition market, worth $24.6bn in 2022 and forecast to grow CAGR 5.9% from 2022 to 2027.1

PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include leading endurance and strength athlete Ross Edgley and influencer Gabby Allen. 

SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA. 

SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and Tottenham Hotspur and CGC Nice football clubs, as well as Official Nutrition Partner to the Milwaukee Bucks, 2021 National Basketball Association Champions. 

For further information, please visit phd.com and scienceinsport.com

 

Euromonitor Passport Database Global Assessment (October 2022)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SRSUURAROUUBRUR
Date   Source Headline
27th Jul 201812:13 pmRNSHolding(s) in Company
19th Jul 20187:00 amRNSHalf Year Trading Update
27th Jun 20187:00 amRNSSIS SPORTS DRINK FUELS GIRO D'ITALIA SUCCESS
19th Jun 20185:00 pmRNSResult of AGM
12th Jun 201812:30 pmRNSDirector/PDMR Shareholding
6th Jun 20184:30 pmRNSDirector/PDMR Shareholding
6th Jun 20187:00 amRNSPosting of AR&A and Notice of AGM
6th Jun 20187:00 amRNSHolding(s) in Company
6th Jun 20187:00 amRNSHolding(s) in Company
4th Jun 201812:00 pmRNSHolding(s) in Company
31st May 201811:00 amRNSPDMR Dealing
29th May 20187:00 amRNSHolding(s) in Company
21st May 20184:21 pmRNSDirector/PDMR Shareholding
14th May 20183:15 pmRNSHolding(s) in Company
4th May 20189:45 amRNSIssue of Equity and Total Voting Rights
16th Apr 20184:57 pmRNSDirector/PDMR Shareholding
13th Apr 20184:32 pmRNSPDMR Dealings - Exercise of Options
22nd Mar 20183:57 pmRNSHolding(s) in Company
22nd Mar 20187:00 amRNSPDMR Dealings Grant of Options
22nd Mar 20187:00 amRNSIssue of Equity
21st Mar 20187:00 amRNSOlympic Champion Adam Peaty Becomes SIS Ambassador
21st Mar 20187:00 amRNSFinal Results
14th Feb 201810:49 amRNSHolding(s) in Company
9th Feb 20183:17 pmRNSHolding(s) in Company
9th Feb 20183:16 pmRNSHolding(s) in Company
8th Feb 20183:37 pmRNSHolding(s) in Company
18th Jan 20184:41 pmRNSIssue of Equity
18th Jan 20187:00 amRNSSiS becomes Official Partner of Manchester United
17th Jan 20183:44 pmRNSHolding(s) in Company
16th Jan 20187:00 amRNSPre-Close Trading Update
6th Dec 20174:47 pmRNSHolding(s) in Company
6th Dec 201710:29 amRNSHolding(s) in Company
6th Dec 201710:27 amRNSHolding(s) in Company
6th Dec 201710:20 amRNSHolding(s) in Company
5th Dec 20177:00 amRNSHolding(s) in Company
4th Dec 20171:22 pmRNSDirector/PDMR Shareholding
1st Dec 201712:44 pmRNSResults of General Meeting and Open Offer
14th Nov 20177:00 amRNSFirm Placing and Open Offer
27th Oct 20177:00 amRNSSiS announces partnership with Rock 'n' Roll
27th Oct 20177:00 amRNSSiS announces three-year deal with USA Triathlon
20th Sep 20179:06 amRNSHalf-year Report - Replacement
20th Sep 20177:00 amRNSHalf-year Report
12th Sep 20172:43 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSTHREE MORE YEARS FOR SiS AND TEAM SKY
4th Aug 20177:00 amRNSSIS to fuel leading British football clubs
3rd Aug 20177:00 amRNSNotice of Results
20th Jul 20177:00 amRNSHalf Year Trading Update
26th Jun 20174:30 pmEQSCavendish Asset Management: Paul Mumford named Small Cap Awards' Fund Manager of the Year
26th Jun 201712:29 pmRNSDirector/PDMR Shareholding
21st Jun 201712:44 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.